Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Natalizumab exerts direct signaling capacity and supports a pro-inflammatory phenotype in some patients with multiple sclerosis.
In vitro Biological Characterization of IFN-β-1a major Glycoforms.
Bridging the Brain Disease Knowledge Gap Through Computational Modeling and Systems Biology
Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study.
Abnormalities of Motor Imagery and Relationship With Depressive Symptoms in Mildly Disabling Relapsing-Remitting Multiple Sclerosis.
Correlates of Executive Functions in Multiple Sclerosis Based on Structural and Functional MR Imaging: Insights from a Multicenter Study.
Ampyra (dalfampridine) medication guide
"Tell me what you want, what you really really want….": asking people with multiple sclerosis about enhancing their participation in physical activity.
[Optical coherence tomography in multiple sclerosis].
Society for Neuroscience Annual Meeting
Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial.
Assessment of confirmed urinary tract infection in patients treated with dalfampridine for multiple sclerosis.
Microvesicles: novel biomarkers for neurological disorders.
Validity and Reliability of a Persian Translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis: A Randomized Controlled Trial.
Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24weeks of therapy with subcutaneous interferon beta-1a three times weekly.
Disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study.
Association mapping of disease loci, by use of a pooled DNA genomic screen.
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.
Evaluation of sexual function in women at two stages of multiple sclerosis.
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis.
Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.
Protective Associations of HDL with Blood Brain Barrier Injury in Multiple Sclerosis Patients.
Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
Complementary and alternative medicine in multiple sclerosis.

Pages